Keep an eye on XBL. Trying to break up from multi year base. Has about 10-11c cash per share. New CEO - Ex Metabolic, Axon and Circadian.
Have been in exclusive negotiations with a major about their fully biodegradable stents. (Opens up arteries then once healed they biodegrade into natural compounds the body can absorb - better alternative to open heart surgery). This period is due to expire in November so I guess watch for insiders buying closer to mid-November.
- Forums
- ASX - By Stock
- exclusive negotiating period almost over
XBL
xceed biotechnology ltd
Keep an eye on XBL. Trying to break up from multi year base. Has...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)